89 results
Page 4 of 5
8-K
EX-99.1
yz5ufohsb4xu9
15 Nov 18
Akers Biosciences Announces Q3 2018 Earnings
7:00am
8-K
EX-10.1
n67v9s n1drzz
31 Oct 18
Entry into a Material Definitive Agreement
9:20am
8-K
pnqvid0y y0zt
19 Jun 18
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:20pm
8-K/A
EX-17.3
iey3m1qt92
5 Jun 18
Departure of Directors or Certain Officers
4:15pm
8-K
EX-3.1
8gnsyo lrluhrsj
26 Dec 17
Akers Biosciences Announces Closing of $6,900,000 Public Offering
12:00am
424B4
b0ec14 mb51v6e
20 Dec 17
Prospectus supplement with pricing info
12:00am